Hiranaka, Y.; Miyazaki, S.; Yurube, T.; Kuroshima, K.; Ryu, M.; Inoue, S.; Kakutani, K.; Tadokoro, K.
Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases. Medicina 2023, 59, 22.
https://doi.org/10.3390/medicina59010022
AMA Style
Hiranaka Y, Miyazaki S, Yurube T, Kuroshima K, Ryu M, Inoue S, Kakutani K, Tadokoro K.
Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases. Medicina. 2023; 59(1):22.
https://doi.org/10.3390/medicina59010022
Chicago/Turabian Style
Hiranaka, Yoshiaki, Shingo Miyazaki, Takashi Yurube, Kohei Kuroshima, Masao Ryu, Shinichi Inoue, Kenichiro Kakutani, and Ko Tadokoro.
2023. "Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases" Medicina 59, no. 1: 22.
https://doi.org/10.3390/medicina59010022
APA Style
Hiranaka, Y., Miyazaki, S., Yurube, T., Kuroshima, K., Ryu, M., Inoue, S., Kakutani, K., & Tadokoro, K.
(2023). Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases. Medicina, 59(1), 22.
https://doi.org/10.3390/medicina59010022
